Tecuro has developed very innovative solutions against pathogen agents based on revolutionnary anorganic chemistry which can find numerous applications in the field of human health. Tecuro addresses unmet needs with huge worldwide market potential. Recent tests have demonstrated high efficacy against COVID-19 virus. First product available on the market in 2021 (Hygienic pads preventing e-coli infections) . Very strong IP. Tecuro has been created by a bunch of very senior managers from the med tech and the chemistry industry (e.g. Johson & Johnson, Procter & Gamble). Tecuro works closely with renomed German and Swiss labs/clinics/companies.
Wanted field of studies